UniProt ID | PP1B_MOUSE | |
---|---|---|
UniProt AC | P62141 | |
Protein Name | Serine/threonine-protein phosphatase PP1-beta catalytic subunit | |
Gene Name | Ppp1cb | |
Organism | Mus musculus (Mouse). | |
Sequence Length | 327 | |
Subcellular Localization | Cytoplasm . Nucleus . Nucleus, nucleoplasm . Nucleus, nucleolus . Highly mobile in cells and can be relocalized through interaction with targeting subunits. In the presence of PPP1R8 relocalizes from the nucleus to nuclear speckles. | |
Protein Description | Protein phosphatase that associates with over 200 regulatory proteins to form highly specific holoenzymes which dephosphorylate hundreds of biological targets. Protein phosphatase (PP1) is essential for cell division, it participates in the regulation of glycogen metabolism, muscle contractility and protein synthesis. Involved in regulation of ionic conductances and long-term synaptic plasticity. Component of the PTW/PP1 phosphatase complex, which plays a role in the control of chromatin structure and cell cycle progression during the transition from mitosis into interphase. In balance with CSNK1D and CSNK1E, determines the circadian period length, through the regulation of the speed and rhythmicity of PER1 and PER2 phosphorylation. May dephosphorylate CSNK1D and CSNK1E.. | |
Protein Sequence | MADGELNVDSLITRLLEVRGCRPGKIVQMTEAEVRGLCIKSREIFLSQPILLELEAPLKICGDIHGQYTDLLRLFEYGGFPPEANYLFLGDYVDRGKQSLETICLLLAYKIKYPENFFLLRGNHECASINRIYGFYDECKRRFNIKLWKTFTDCFNCLPIAAIVDEKIFCCHGGLSPDLQSMEQIRRIMRPTDVPDTGLLCDLLWSDPDKDVQGWGENDRGVSFTFGADVVSKFLNRHDLDLICRAHQVVEDGYEFFAKRQLVTLFSAPNYCGEFDNAGGMMSVDETLMCSFQILKPSEKKAKYQYGGLNSGRPVTPPRTANPPKKR | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MADGELNVD ------CCCCCCCHH | 33.25 | - | |
10 | Phosphorylation | DGELNVDSLITRLLE CCCCCHHHHHHHHHH | 19.86 | 20469934 | |
13 | Phosphorylation | LNVDSLITRLLEVRG CCHHHHHHHHHHHCC | 22.13 | 20469934 | |
25 | Acetylation | VRGCRPGKIVQMTEA HCCCCCCCEEEEEHH | 42.24 | 23236377 | |
25 | Malonylation | VRGCRPGKIVQMTEA HCCCCCCCEEEEEHH | 42.24 | 26320211 | |
25 | Ubiquitination | VRGCRPGKIVQMTEA HCCCCCCCEEEEEHH | 42.24 | - | |
41 | Phosphorylation | VRGLCIKSREIFLSQ HHCCEECCCCHHHCC | 18.42 | 26745281 | |
47 | Phosphorylation | KSREIFLSQPILLEL CCCCHHHCCCEEEEE | 24.14 | 26745281 | |
97 | Ubiquitination | GDYVDRGKQSLETIC HHHCHHCHHHHHHHH | 37.29 | - | |
112 | Acetylation | LLLAYKIKYPENFFL HHHHHHCCCCCCEEE | 51.07 | 22826441 | |
112 | Ubiquitination | LLLAYKIKYPENFFL HHHHHHCCCCCCEEE | 51.07 | 22790023 | |
128 | Phosphorylation | RGNHECASINRIYGF CCCCHHHHHHHHEEC | 31.86 | 23684622 | |
136 | Phosphorylation | INRIYGFYDECKRRF HHHHEECHHHHHHHH | 13.38 | - | |
140 | Ubiquitination | YGFYDECKRRFNIKL EECHHHHHHHHCCCH | 44.56 | - | |
140 | Acetylation | YGFYDECKRRFNIKL EECHHHHHHHHCCCH | 44.56 | 68947 | |
140 | Malonylation | YGFYDECKRRFNIKL EECHHHHHHHHCCCH | 44.56 | 26320211 | |
146 | Ubiquitination | CKRRFNIKLWKTFTD HHHHHCCCHHHHHHH | 49.77 | 22790023 | |
146 | Acetylation | CKRRFNIKLWKTFTD HHHHHCCCHHHHHHH | 49.77 | 22826441 | |
149 | Ubiquitination | RFNIKLWKTFTDCFN HHCCCHHHHHHHHCC | 44.17 | - | |
150 | Phosphorylation | FNIKLWKTFTDCFNC HCCCHHHHHHHHCCC | 21.86 | 23984901 | |
152 | Phosphorylation | IKLWKTFTDCFNCLP CCHHHHHHHHCCCCH | 36.77 | 23984901 | |
170 | S-palmitoylation | IVDEKIFCCHGGLSP HCCCCEEECCCCCCC | 1.58 | 28680068 | |
171 | S-palmitoylation | VDEKIFCCHGGLSPD CCCCEEECCCCCCCC | 2.02 | 28680068 | |
181 | Phosphorylation | GLSPDLQSMEQIRRI CCCCCHHHHHHHHHH | 31.42 | 28464351 | |
192 | Phosphorylation | IRRIMRPTDVPDTGL HHHHCCCCCCCCCCC | 38.98 | 22817900 | |
197 | Phosphorylation | RPTDVPDTGLLCDLL CCCCCCCCCCHHHHH | 24.53 | 22817900 | |
206 | Phosphorylation | LLCDLLWSDPDKDVQ CHHHHHCCCCCCCCC | 38.95 | 19854140 | |
233 | Ubiquitination | FGADVVSKFLNRHDL ECHHHHHHHHCHHCH | 42.11 | - | |
259 | Ubiquitination | DGYEFFAKRQLVTLF HCHHHHHHCCEEECC | 35.20 | - | |
259 | Acetylation | DGYEFFAKRQLVTLF HCHHHHHHCCEEECC | 35.20 | 19809623 | |
303 | Ubiquitination | KPSEKKAKYQYGGLN CCCCCCCCCCCCCCC | 41.59 | 22790023 | |
304 | Phosphorylation | PSEKKAKYQYGGLNS CCCCCCCCCCCCCCC | 16.30 | 28833060 | |
306 | Phosphorylation | EKKAKYQYGGLNSGR CCCCCCCCCCCCCCC | 15.29 | 28833060 | |
311 | Phosphorylation | YQYGGLNSGRPVTPP CCCCCCCCCCCCCCC | 41.02 | 26824392 | |
316 | Phosphorylation | LNSGRPVTPPRTANP CCCCCCCCCCCCCCC | 30.20 | 26824392 | |
320 | Phosphorylation | RPVTPPRTANPPKKR CCCCCCCCCCCCCCC | 36.24 | 25266776 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of PP1B_MOUSE !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PP1B_MOUSE !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PP1B_MOUSE !! |
Kegg Drug | ||||||
---|---|---|---|---|---|---|
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Solid tumor proteome and phosphoproteome analysis by high resolutionmass spectrometry."; Zanivan S., Gnad F., Wickstroem S.A., Geiger T., Macek B., Cox J.,Faessler R., Mann M.; J. Proteome Res. 7:5314-5326(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-316, AND MASSSPECTROMETRY. |